Variant report
Variant | nsv436609 |
---|---|
Chromosome Location | chr9:878258-882957 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:879356..881162-chr9:885762..888045,2 | K562 | blood: | |
2 | chr9:879492..881659-chr9:881684..884926,3 | MCF-7 | breast: | |
3 | chr9:875320..878036-chr9:881518..883087,2 | MCF-7 | breast: | |
4 | chr9:879492..881659-chr9:881684..884926,3 | MCF-7 | breast: | |
5 | chr9:873202..875175-chr9:876431..878577,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs555155003 | chr9:878272-878273 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs575096583 | chr9:878339-878340 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544070811 | chr9:878341-878342 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs556290037 | chr9:878348-878349 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs188004155 | chr9:878377-878378 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs544666006 | chr9:878422-878423 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548775218 | chr9:878423-878424 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs564913165 | chr9:878441-878442 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs569235019 | chr9:878443-878444 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs565477022 | chr9:878457-878458 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs540934478 | chr9:878471-878472 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
12 | rs560886528 | chr9:878526-878527 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs145930081 | chr9:878537-878538 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs55873183 | chr9:878563-878564 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs191269349 | chr9:878622-878623 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
16 | rs570035399 | chr9:878659-878660 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531075122 | chr9:878679-878680 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
18 | rs375905206 | chr9:878682-878683 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182737543 | chr9:878683-878684 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
20 | rs138520852 | chr9:878724-878725 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566066509 | chr9:878737-878738 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534967466 | chr9:878770-878771 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs141667959 | chr9:878797-878798 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
24 | rs544820019 | chr9:878829-878830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs57858982 | chr9:878831-878832 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs563329559 | chr9:878836-878837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs186644226 | chr9:878848-878849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557624266 | chr9:878854-878855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs370587392 | chr9:878873-878874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs576024466 | chr9:878887-878888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs538749017 | chr9:878923-878924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs558224586 | chr9:878927-878928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192622734 | chr9:878960-878961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs540670038 | chr9:878978-878979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs560824842 | chr9:878981-878982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs531871731 | chr9:879026-879027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs75577072 | chr9:879041-879042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs114616246 | chr9:879055-879056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs532452733 | chr9:879067-879068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs548672388 | chr9:879068-879069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs184647007 | chr9:879085-879086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs559633166 | chr9:879117-879118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528491626 | chr9:879129-879130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs548630208 | chr9:879143-879144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs4740955 | chr9:879145-879146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs187614643 | chr9:879160-879161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs192908246 | chr9:879167-879168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs551168899 | chr9:879169-879170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs185115278 | chr9:879191-879192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs150745015 | chr9:879220-879221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Gastric cancer | 16715143 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 20531469 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Cancer | 21272361 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:878200-878400 | Enhancers | Right Ventricle | heart |
2 | chr9:878200-878600 | Bivalent Enhancer | Left Ventricle | heart |
3 | chr9:878400-878800 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
4 | chr9:878400-878800 | Enhancers | Rectal Mucosa Donor 31 | rectum |
5 | chr9:878400-879000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr9:878600-878800 | Enhancers | Adipose Nuclei | Adipose |
7 | chr9:879000-881800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr9:880400-882000 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
9 | chr9:880600-881200 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
10 | chr9:880800-881000 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr9:881800-883600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr9:882000-882400 | Bivalent Enhancer | Primary Natural Killer cells fromperipheralblood | blood |